Related Articles
What causes p53 mutations in patients with lung cancer?
Tripartite motif-containing 29 as a novel biomarker in non-small cell lung cancer
Clinical predictors of response to single‑agent immune checkpoint inhibitors in chemotherapy‑pretreated non‑small cell lung cancer
FHIT promoter methylation status, low protein and high mRNA levels in patients with non-small cell lung cancer
Prospective evaluation of C-reactive protein, smoking and lung cancer death in the Third National Health and Nutrition Examination Survey